z-logo
open-access-imgOpen Access
CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED EFFICACY ANALYSIS OF PHASE 3 CLINICAL TRIALS ACROSS BASELINE RHEUMATOID FACTOR QUARTILES
Author(s) -
Ricardo Machado Xavier,
Yoshiya Tanaka,
Zhanguo Li,
Nevsun İnanç,
Nicola Tilt,
Cara L. Cuite,
Carine Saadoun,
Tsutomu Takeuchi
Publication year - 2021
Publication title -
anais do congresso brasileiro de reumatologia 2020
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2020.17164
Subject(s) - certolizumab pegol , rheumatoid arthritis , medicine , quartile , rheumatoid factor , clinical trial , adalimumab , confidence interval

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here